Literature DB >> 10963043

Role of dopamine in malignant tumor growth.

S Basu1, P S Dasgupta.   

Abstract

The regulatory role of dopamine, a monoamine neurotransmitter and/or a neurohormone in controlling the secretion of several anterior pituitary hormones, cardiovascular, and renal functions, has already been extensively used by clinicians for therapeutic purposes. In addition to these important functions of dopamine, some recent reports also indicate its novel role in regulating malignant cell proliferation and controlling immune functions in tumor-bearing animals. Therefore, in this article, we discuss all the relevant information correlating dopamine and malignant tumor growth in order to understand the host-tumor relationship at the level of a neurotransmitter and/or a neurohormone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963043     DOI: 10.1385/ENDO:12:3:237

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  73 in total

1.  Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.

Authors:  M M Wick
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

Review 2.  Motor effects of serotonin in the central nervous system.

Authors:  S C Gerson; R J Baldessarini
Journal:  Life Sci       Date:  1980-10-20       Impact factor: 5.037

Review 3.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 4.  Prolactin and neuroimmunomodulation: in vitro and in vivo observations.

Authors:  I C Chikanza
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

5.  L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.

Authors:  S ThyagaRajan; S K Quadri
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

6.  Enhanced tumor growth in brain dopamine-depleted mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.

Authors:  S Basu; P S Dasgupta; J R Chowdhury
Journal:  J Neuroimmunol       Date:  1995-07       Impact factor: 3.478

7.  The role of central dopaminergic processes in chemical carcinogenesis.

Authors:  V K Gurkalo; M A Zabezhinski
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

8.  Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat.

Authors:  E Mezey; G Eisenhofer; S Hansson; B Hunyady; B J Hoffman
Journal:  Neuroendocrinology       Date:  1998-05       Impact factor: 4.914

9.  [Effects of apomorphine and haloperidol on experimental hepatocarcinogenesis].

Authors:  V K Gurkalo; M A Zabezhinskiĭ
Journal:  Vopr Onkol       Date:  1983

10.  Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.

Authors:  M M Wick
Journal:  Cancer Treat Rep       Date:  1979-06
View more
  14 in total

Review 1.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

2.  A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma.

Authors:  Mingxin Zhang; Xiaoyan Liu; Xiang Liu; Hanzhong Li; Wei Sun; Yushi Zhang
Journal:  Int Urol Nephrol       Date:  2019-11-16       Impact factor: 2.370

3.  Dopamine blocks stress-mediated ovarian carcinoma growth.

Authors:  Myrthala Moreno-Smith; Chunhua Lu; Mian M K Shahzad; Guillermo N Armaiz Pena; Julie K Allen; Rebecca L Stone; Lingegowda S Mangala; Hee Dong Han; Hye Sun Kim; Donna Farley; Gabriel Lopez Berestein; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

4.  Cancer incidence in young and middle-aged people with schizophrenia: nationwide cohort study in Taiwan, 2000-2010.

Authors:  L Y Chen; Y N Hung; Y Y Chen; S Y Yang; C H Pan; C C Chen; C J Kuo
Journal:  Epidemiol Psychiatr Sci       Date:  2016-11-21       Impact factor: 6.892

Review 5.  Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.

Authors:  Monojit Debnath
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-11       Impact factor: 4.147

Review 6.  Understanding the role of dopamine in cancer: past, present and future.

Authors:  Christopher E Grant; Amy L Flis; Bríd M Ryan
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

Review 7.  Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.

Authors:  Chandrani Sarkar; Debanjan Chakroborty; Sujit Basu
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-11       Impact factor: 4.147

8.  Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2.

Authors:  Sutapa Sinha; Pawan Kumar Vohra; Resham Bhattacharya; Shamit Dutta; Shirshendu Sinha; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

9.  The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

Authors:  Francesca R Buttarelli; Alessandra Fanciulli; Clelia Pellicano; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

10.  Role of Dopamine Receptors in the Anticancer Activity of ONC201.

Authors:  Christina Leah B Kline; Marie D Ralff; Amriti R Lulla; Jessica M Wagner; Phillip H Abbosh; David T Dicker; Joshua E Allen; Wafik S El-Deiry
Journal:  Neoplasia       Date:  2017-12-05       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.